BridgeMD
New treatment option for Anal Cancer
Official title Host Genome Methylation: a Screening Tool in Anal Cancer Detection
ClinicalTrials.gov ID: NCT06792604
What this study is testing
- What it's testing
- In January 2023, the first recommendations for anal cancer screening were issued by the French National Society of Coloproctology (SNFCP). These were the world's first national recommendations for anal cancer screening for at-risk patients, not limited to people living with HIV.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥ 18 years)
- Eligible for anal cancer screening according to the SNFCP guidelines (with extension to men who have received solid organ transplants for more than...
- MSM (men who have sex with men) aged over 30 living with HIV
- Patients who have received a solid organ transplant for more than 10 years
- Women with a history of vulvar lesions or vulvar cancer Non-
You likely can't join if
- 1) Refusal of anal self-sampling on inclusion
See the full eligibility criteria
- Adults (age ≥ 18 years)
- Eligible for anal cancer screening according to the SNFCP guidelines (with extension to men who have received solid organ transplants for more than 10 years):
- MSM (men who have sex with men) aged over 30 living with HIV
- Patients who have received a solid organ transplant for more than 10 years
- Women with a history of vulvar lesions or vulvar cancer Non-
- Proctological follow-up for a current high-grade anal lesion or cancer
- Pregnant or breastfeeding women
- Subject deprived of liberty or under legal protection
- Non-affiliation with social security system
- Refusal to participate expressed by the patient
- 1) Refusal of anal self-sampling on inclusion
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.